Bupivacaine HCl PK and Safety in Augmentation Mammoplasty
Status:
Completed
Trial end date:
2018-11-05
Target enrollment:
Participant gender:
Summary
This is a Phase 4, randomized, open-label study of bupivacaine HCl administered either by
instillation into the surgical site or by injection into the surgical site in subjects
undergoing bilateral submuscular augmentation mammoplasty under general anesthesia.